fincash logo SOLUTIONS

Fincash » Search » Orchid Pharma Ltd

Orchid Pharma Ltd

Updated on July 11, 2024

Stock/Share Code - ORCHIDPHAR

Orchid Pharma formerly Orchid Chemicals & Pharmaceuticals Limited, is involved in the development, manufacture and marketing of various bulk actives, formulations and nutraceuticals.

Below is the details of ORCHIDPHAR Orchid Pharma Ltd

Market Cap₹48.49 Cr.
Current Price ₹5.45
52 Week High / Low Price /
Face Value₹10
Stock P/E
Book Value₹118.72
Dividend Yield0.00 %
ROCE-7.23 %
ROE-99.49 %
Sales Growth (3yrs)-12.53 %
IndustryPharmaceuticals - Indian - Bulk Drugs
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Stock is trading at 0.05 times its book value Debtor days have improved from 72.71 to 47.93 days.
Cons: Company has low interest coverage ratio. The company has delivered a poor growth of -21.87% over past five years. Promoter holding is low: 26.68% Contingent liabilities of Rs.142.90 Cr. Company might be capitalizing the interest cost Promoters have pledged 99.96% of their holding.

Orchid Pharma Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Divi's Lab. 51.94 ₹82,900.53 Cr. 0.51 ₹492.06 Cr. 80.61 48.81 1730.47 25.19
2. ₹42,032.3 Cr. 0.65 ₹106.9 Cr. -64.73 -9.02 3527.86 9.23
3. Jubilant Life 13.50 ₹12,477.17 Cr. 0.64 ₹260.49 Cr. 248.25 0.24 2391.41 15.46
4. Granules India 22.60 ₹7,765.53 Cr. 0.32 ₹111.45 Cr. 33.89 23.57 735.60 17.15
5. Aarti Drugs 31.46 ₹6,319.31 Cr. 0.07 ₹85.45 Cr. 280.62 34.34 544.67 20.87
6. Shilpa Medicare 23.66 ₹4,289.13 Cr. 0.21 ₹86.31 Cr. 159.66 38.43 222.86 12.62
7. Sequent Scien. 40.58 ₹3,221.37 Cr. 0.15 ₹20.92 Cr. 82.55 11.60 310.27 12.29
8. Orchid Pharma ₹48.49 Cr. 0.00 -₹54.31 Cr. -57.10 -32.06 110.11 -7.23

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Orchid Pharma Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020
Sales -135209144156131142148162136131129110
YOY Sales Growth %-25.80%11.51%-19.86%-23.96%-3.08%-31.94%2.92%4.03%3.92%-8.06%-13.38%-32.06%
Expenses -167186131148145146136170145129138138
Material Cost %63%54%44%44%52%42%48%49%49%42%43%58%
Employee Cost %16%9%14%14%15%14%13%13%15%16%17%17%
Operating Profit-3224148-14-312-8-92-9-28
OPM %-24%11%9%5%-11%-2%8%-5%-7%1%-7%-25%
Other Income558115132265776
Profit before tax-131-81-88-103-46-23-18-13-36-25-35-54
Tax %13%13%12%10%-0%0%0%0%0%0%0%0%
Net Profit-114-70-77-92-46-23-18-13-36-25-35-54
EPS in Rs-12.87-7.91-8.68-10.38-5.17-2.60-2.08-1.51-4.00-2.83-3.91-13.31

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Sep 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Sales -1,2391,1911,2501,6631,7361,9071,736879755644584505
Sales Growth %35.71%-3.83%4.90%33.09%4.39%9.81%-8.94%-49.35%-14.10%-14.72%-9.40%-13.40%
Expenses -8941,0311,4231,3151,4551,8331,345705740622766550
Material Cost %35.08%42.83%62.03%47.37%45.26%50.26%45.00%47.68%48.65%51.36%47.66%47.53%
Manufacturing Cost %11.71%11.70%10.98%11.24%12.12%13.64%12.89%13.38%13.76%15.29%15.52%0.00%
Employee Cost %8.65%10.61%13.00%9.05%9.29%12.89%10.84%9.49%9.99%12.91%13.64%16.12%
Other Cost %16.72%21.41%27.81%11.39%17.12%19.34%8.74%9.65%25.58%16.99%54.41%45.11%
Operating Profit345160-173349282743911741522-182-44
OPM %28%13%-14%21%16%4%23%20%2%3%-31%-9%
Other Income73881,0256912614784-28-592021824
Profit before tax239-3746017480-544-383-292-537-401-101-150
Tax %23%-42%28%8%-29%2%50%6%9%12%0%0%
Net Profit185-52331159103-530-191-274-489-355-101-150
EPS in Rs27.270.0044.9422.0514.
Dividend Payout %11%-14%21%13%20%0%0%0%0%0%0%0%

Compounded Sales Growth

  • 10 Years:: -8.66%
  • 5 Years:: -21.87%
  • 3 Years:: -12.53%
  • TTM:: -13.40%

Compounded Profit Growth

  • 10 Years:: 5.63%
  • 5 Years:: 8.56%
  • 3 Years:: 17.63%
  • TTM:: -18.93%

Return on Equity

  • 10 Years:: -29.77%
  • 5 Years:: -36.98%
  • 3 Years:: -33.22%
  • 1 Year:: 0.00%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Sep 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -667070707070858989898941
Equity Capital65.8570.4470.4470.4470.4470.4585.2688.9688.9688.9688.9640.82
Other Liabilities -8289551,1796867561,031506577595683518154
Trade Payables21930928326240456229635341232727062
Advance from Customers000116951122120311
Other liability items60864689641328441819920316335423892
Total Liabilities3,4694,2223,7883,8883,8994,7234,1563,9633,3583,2112,9931,712
Fixed Assets -1,4141,8661,4631,5961,9312,4831,6971,5401,4021,2911,1611,049
Gross Block1,9612,5362,1842,4532,9193,6602,8902,8931,5401,4251,425
Accumulated Depreciation5476697218579871,1771,1931,353139133263
Other Assets -1,3251,6871,7331,8321,4681,7562,0532,0171,5431,5231,553584
Trade receivables5236597164819118429037520814514166
Cash Equivalents234232519317022390313256301324174
Loans n Advances2203302892734245004254254260821
Other asset items-73-870305160550706693840832840187
Total Assets3,4694,2223,7883,8883,8994,7234,1563,9633,3583,2112,9931,712

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Sep 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -21635-40312764175-37021140261580
Profit from operations397.77182.26-65.32422.83345.29165.58761.75204.04-42.8048.30134.1424.75
Other WC items0.
Working capital changes-149.20-144.7290.93-49.55447.419.33-668.577.26449.56-35.68-114.6845.22
Direct taxes-32.19-2.74-65.89-61.16-28.800.00-47.030.00-5.16-7.04-4.280.00
Other operating items0.
Exceptional CF items0.
Cash from Investing Activity --554-4661,413-362-309-9981,334-1-176-2845167
Fixed assets purchased-553-462-223-377-292-1,152-83-1-9-6-7-4
Fixed assets sold111,63719177100000
Investments purchased0000-18000-0000
Investments sold0000077000000
Interest received0000000015121524
Dividends received030300000000
Invest in subsidiaries-1-9-1-700000000
Other investing items0000001,4160-182-3437147
Cash from Financing Activity -248429-1,071-73-478676-597-287-46533-0-250
Proceeds from shares11100000741800040
Proceeds from borrowings72399073162791645866130390754
Repayment of borrowings-331-394-1,413-336-301-173-484-53-103-10-1,044
Interest paid fin-121-195-288-167-245-351-150-265-362-4-0-0
Dividends paid-23-25-8-82-250000000
Financial liabilities-0-0-1-100000000
Other financing items0-56-93-114-824743-10200000
Net Cash Flow-89-3302-123-24-147367-76-2391160-3

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Sep 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %13%4%-11%9%8%-2%1%2%-3%-3%-5%-7%
Debtor Days154202209106193561156101828848
Inventory Turnover0.820.851.471.751.451.922.382.

Announcements & News

Recent Announcements

Credit Ratings

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Orchid Pharma Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.